Photopharmacology and photoresponsive drug delivery
Chemical Society Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Light
serves
as
an
excellent
external
stimulus
due
to
its
high
spatial
and
temporal
resolution.
The
use
of
light
regulate
biological
processes
has
evolved
into
a
vibrant
field
over
the
past
decade.
Employing
on
chemical
substances
such
bioactive
molecules
drug
delivery
systems
offers
promising
therapeutic
approach
achieve
precise
control
processes.
In
this
review,
we
provide
overview
advancements
in
optochemical
technologies
for
controlling
(photopharmacology)
(photoresponsive
delivery),
with
emphasis
their
relationship
biomedical
applications.
Gaining
deeper
understanding
underlying
mechanisms
emerging
research
will
facilitate
development
optochemically
controlled
photoresponsive
systems,
further
enhancing
Language: Английский
A Bright Future for Photopharmaceuticals Addressing Central Nervous System Disorders: State of the Art and Challenges Toward Clinical Translation
Medicinal Research Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 5, 2025
ABSTRACT
Photopharmacology
is
an
innovative
approach
that
uses
light
to
activate
drugs.
This
method
offers
the
potential
for
highly
localized
and
precise
drug
activation,
making
it
particularly
promising
treatment
of
neurological
disorders.
Despite
enticing
prospects
photopharmacology,
its
application
treat
human
central
nervous
system
(CNS)
diseases
remains
be
demonstrated.
In
this
review,
we
provide
overview
prominent
strategies
design
activation
photopharmaceutical
agents
in
field
neuroscience.
Photocaged
photoswitchable
drugs
bioactive
molecules
are
discussed,
instructive
list
examples
provided
highlight
compound
strategies.
Special
emphasis
placed
on
photoactivatable
compounds
modulation
glutamatergic,
GABAergic,
dopaminergic,
serotonergic
neurotransmission
conditions,
as
well
various
photoresponsive
with
improved
pain
management.
Compounds
holding
promise
clinical
translation
discussed
in‐depth
their
future
applications
assessed.
Neurophotopharmaceuticals
have
yet
achieve
breakthrough
clinic,
both
delivery
not
reached
full
maturity.
However,
by
describing
current
state
art
providing
illustrative
case
studies,
offer
a
perspective
opportunities
neurophotopharmacology
focused
addressing
CNS
Language: Английский
Adenosine A2A signaling in mood disorders: how far have we come?
IBRO Neuroscience Reports,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 1, 2024
Language: Английский
Photoresponsive Adenosine Derivatives for the Optical Control of Adenosine A2A Receptors in Living Cells
Harufumi Suzuki,
No information about this author
Tomohiro Doura,
No information about this author
Yuya Matsuba
No information about this author
et al.
ACS Chemical Biology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 11, 2024
The
use
of
photoresponsive
ligands
to
optically
control
proteins
interest,
known
as
photopharmacology,
is
a
powerful
technique
for
elucidating
cellular
function
in
living
cells
and
animals
with
high
spatiotemporal
resolution.
adenosine
A
Language: Английский
Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A2a Adenosine Receptor Ligands
Torben Saßmannshausen,
No information about this author
Hannah Glover,
No information about this author
Matilde Trabuco
No information about this author
et al.
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
146(47), P. 32670 - 32677
Published: Nov. 13, 2024
Photoisomerization
of
ligands
is
a
key
process
in
the
field
photopharmacology.
Thus,
kinetics
and
efficiency
this
initial
photoreaction
are
great
importance
but
can
be
influenced
by
molecular
environment
binding
pocket
resulting
confinement
reaction
pathway.
In
study,
we
investigated
photoisomerization
an
azobenzene
derivative
anti-Parkinson's
drug
istradefylline.
To
identify
impact
pocket,
ligand
was
examined
solution
bound
to
its
target
protein,
A
Language: Английский
Photoswitch dissociation from a G protein-coupled receptor resolved by time-resolved serial crystallography
Hannah Glover,
No information about this author
Torben Saßmannshausen,
No information about this author
Quentin Bertrand
No information about this author
et al.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 30, 2024
G
protein-coupled
receptors
(GPCRs)
are
the
largest
family
of
cell
surface
in
humans.
The
binding
and
dissociation
ligands
tunes
inherent
conformational
flexibility
these
important
drug
targets
towards
distinct
functional
states.
Here
we
show
how
to
trigger
resolve
protein-ligand
interaction
dynamics
within
human
adenosine
A
Language: Английский